| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |